相关实验视频

Updated: May 23, 2025

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
09:01

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

13.9K

[脊髓边缘区域淋巴瘤与POD24的临床特征和预后]

L Wang1, Q Shi2, W L Zhao2

  • 1Shanghai Institute of Hematology, State Key Laboratory of Genomics and Disease, National Translational Medicine Research Center, Department of Hematology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200025, China Department of Hematology, General Hospital of Taiyuan Iron and Steel (Group) Company Limited (The Sixth Hospital of Shanxi Medical University, The Sixth Clinical Medical College of Shanxi Medical University), Taiyuan 030000, China.

Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
|March 10, 2025
PubMed
概括

24个月内的进展 (POD24) 和组织转变是脏边缘区域淋巴瘤 (SMZL) 患者的不良预后因素,POD24增加了转变的风险. 最初的治疗失败独立地影响POD24.

关键词:
在24个月内疾病进展.淋巴瘤,B细胞,边缘区域预测 预后 预测 预测脏的新生瘤 脏的新生瘤

更多相关视频

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling09:08

Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling

Published on: October 14, 2021

5.3K
Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.1K

相关概念视频